Skip to main content

Table 5 Baseline characteristics of patients with Non-Diabetes Mellitus

From: Statins and clinical outcomes in hospitalized COVID-19 patients with and without Diabetes Mellitus: a retrospective cohort study with propensity score matching

   Unmatched Propensity score matched
Characteristic Cohort (n = 509) Inpatient Statin (n = 114) Non Statin (n = 395) p-value Inpatient Statin (n = 94) Non Statin (n = 94) p-value
Age, (years) n (%)
 Median (IQR) 65 (52–73) 67 (57.75–77) 64 (49–73) 0.006 67 (57–75.5) 67.5 (59.75–76) 0.75
 18–30 23 (4.5) 0 23 (5.8) 0 2 (2.1)
 31–45 54 (10.6) 6 (5.3) 48 (12.2) 3 (3.2) 10 (10.6)
 46–64 176 (34.6) 42 (36.8) 134 (33.9) 36 (38.3) 26 (27.7)
 ≥ 65 256 (50.3) 66 (57.9) 190 (48.1) 55 (58.5) 56 (59.6)
Sex, n (%)
 Male 273 (53.6) 71 (62.3) 202 (51.1) 0.04 55 (58.5) 57 (60.6) 0.77
 Female 236 (46.4) 43 (37.7) 193 (48.9) 39 (41.5) 37 (39.4)
Race, n (%)
 Blacks 374 (73.5) 78 (68.4) 296 (74.9) 0.17 68 (72.3) 72 (76.6) 0.5
 Other races 135 (26.5) 36 (31.6) 99 (25.1) 26 (27.7) 22 (23.4)
BMI
 Median (IQR) 28.8 (24.9–35.8) 28 (23.98–34.5) 29.2 (25.4–36.43) 0.07 29.3 (24.63–34.8) 26.95 (24.33–32.7) 0.4
 < 18.5 (underweight) 20 (3.9) 5 (4.4) 15 (3.8) 4 (4.3) 5 (5.3)
 18.5–24.9 (normal) 113 (22.2) 36 (31.6) 77 (19.5) 24 (25.5) 23 (24.5)
 25–29.9 (overweight) 148 (29.1) 25 (21.9) 123 (31.1) 22 (23.4) 31 (33)
 ≥ 30 (obese) 227 (44.6) 48 (42.1) 179 (45.3) 44 (46.8) 35 (37.2)
Comorbidities, n (%)
 Preexisting lung diseases 172 (33.8) 41 (36) 131 (33.2) 0.58 36 (38.3) 31 (33) 0.45
 Coronary artery disease 72 (14.1) 34 (29.8) 38 (9.6)  < 0.001 26 (27.7) 22 (23.4) 0.5
 Hypertension 378 (74.3) 103 (90.4) 275 (69.6)  < 0.001 84 (89.4) 76 (80.9) 0.1
 Hyperlipidemia 120 (23.6) 56 (49.1) 64 (16.2)  < 0.001 38 (40.4) 37 (39.4) 0.88
 Congestive Heart Failure 59 (11.6) 25 (21.9) 34 (8.6)  < 0.001 20 (21.3) 21 (22.3) 0.86
 Stroke 55 (10.8) 28 (24.6) 27 (6.8)  < 0.001 18 (19.1) 20 921.3) 0.72
 Cancer 53 (10.4) 7 (6.1) 46 (11.6) 0.09 7 (7.4) 4 (4.3) 0.35
 Chronic liver disease 22 (4.3) 3 (2.6) 19 (4.8) 0.31 3 (3.2) 5 (5.3) 0.47
 Chronic kidney disease 45 (8.8) 17 (14.9) 28 (7.1) 0.01 12 (12.8) 13 (13.8) 0.83
 ESRD on dialysis 45 (8.8) 13 (11.4) 32 (8.1) 0.27 12 (12.8) 10 (10.6) 0.65
 Smoking 211 (41.5) 55 (48.2) 156 (39.5) 0.1 43 (45.7) 48 (51.1) 0.47
 Insurance
 Uninsured 2 (0.4) 0 2 (0.5) 0.08 0 1 (1.1) 0.44
 Medicaid 155 (30.5) 29 (25.4) 126 (31.9) 21 (22.3) 23 (24.5)
 Medicare 299 (58.7) 78 (68.4) 221 (55.9) 66 (70.2) 67 (71.3)
 Private 53 (10.4) 7 (6.1) 46 (11.6) 7 (7.4) 3 (3.2)
Days from symptom onset to hospital presentation
 0–5 360 (70.7) 90 (78.9) 270 (68.4) 0.06 77 (81.9) 66 (70.2) 0.25
 6–10 88 (17.3) 11 (9.6) 77 (19.5) 9 (9.6) 18 (19.1)
 11–15 30 (5.9) 5 (4.4) 25 (6.3) 5 (5.3) 6 (6.4)
 16 +  10 (2) 3 (2.6) 7 (1.8) 3 (3.2) 4 (4.3)
CURB-65 at presentation
 0 145 (28.5) 18 (15.8) 127 (32.2) 0.004 14 (14.9) 21 (22.3) 0.17
 1 157 (30.8) 43 (37.7) 114 (28.9) 36 (38.3) 27 (28.7)
 2 129 (25.3) 30 (26.3) 99 (25.1) 27 (28.7) 30 (31.9)
 3 57 (11.2) 20 (17.5) 37 (9.4) 15 (16) 11 (11.7)
 4 12 (2.4) 1 (0.9) 11 (2.8) 0 4 (4.3)
 5 7 (1.4) 2 (1.8) 5 (1.3) 2 (2.1) 1 (1.1)